Stonegate Investment Group LLC boosted its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 24.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,022 shares of the financial services provider’s stock after buying an additional 1,598 shares during the quarter. Stonegate Investment Group LLC’s holdings in MetLife were worth $657,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of MET. Scientech Research LLC purchased a new stake in MetLife in the 2nd quarter worth about $264,000. Creative Planning raised its holdings in shares of MetLife by 3.1% in the second quarter. Creative Planning now owns 127,003 shares of the financial services provider’s stock worth $8,914,000 after buying an additional 3,865 shares during the period. NewEdge Advisors LLC lifted its stake in shares of MetLife by 1.6% during the 2nd quarter. NewEdge Advisors LLC now owns 47,203 shares of the financial services provider’s stock worth $3,313,000 after acquiring an additional 737 shares during the last quarter. Quarry LP boosted its holdings in MetLife by 155.3% during the 2nd quarter. Quarry LP now owns 2,088 shares of the financial services provider’s stock valued at $147,000 after acquiring an additional 1,270 shares during the period. Finally, Truist Financial Corp grew its position in MetLife by 13.2% in the 2nd quarter. Truist Financial Corp now owns 1,938,609 shares of the financial services provider’s stock valued at $136,071,000 after acquiring an additional 226,784 shares during the last quarter. Institutional investors own 94.99% of the company’s stock.
MetLife Price Performance
Shares of MET stock opened at $85.73 on Wednesday. The stock’s 50-day moving average is $83.88 and its 200 day moving average is $80.22. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $59.36 billion, a P/E ratio of 17.28, a PEG ratio of 0.65 and a beta of 1.07.
MetLife Dividend Announcement
Wall Street Analyst Weigh In
Several research firms have recently weighed in on MET. Piper Sandler lifted their target price on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. JPMorgan Chase & Co. boosted their price objective on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. TD Cowen raised their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. Barclays boosted their price target on MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, January 6th. Finally, Wells Fargo & Company reduced their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $90.46.
View Our Latest Stock Report on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Are Penny Stocks a Good Fit for Your Portfolio?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- The Significance of Brokerage Rankings in Stock Selection
- What Does the Future Hold for Eli Lilly?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.